Statin therapy is associated with improved survival in incident peritoneal dialysis patients: propensity-matched comparison

Title
Statin therapy is associated with improved survival in incident peritoneal dialysis patients: propensity-matched comparison
Author(s)
도준영이정은[이정은]오국환[오국환]최규헌[최규헌]김순배[김순배]김용수[김용수]김용림[김용림]김대중[김대중]
Keywords
CORONARY-HEART-DISEASE; RENAL-DISEASE; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; KIDNEY-DISEASE; HEMODIALYSIS; MORTALITY; EPIDEMIOLOGY; CHOLESTEROL; PREVENTION
Issue Date
201112
Publisher
OXFORD UNIV PRESS
Citation
NEPHROLOGY DIALYSIS TRANSPLANTATION, v.26, no.12, pp.4090 - 4094
Abstract
Background. Patients with end-stage renal disease (ESRD) have a greatly increased risk of premature cardiovascular disease. Peritoneal dialysis (PD) patients have more atherogenic lipid profiles than haemodialysis patients. In this retrospective cohort study, we evaluated whether statin use is associated with improved mortality in incident PD patients. Methods. The study population included consecutive new PD patients (>= 18 years old) from seven PD centres in Korea, between January 2003 and December 2008. The clinical outcome was mortality. A propensity score (PS) comprising demographic, clinical and laboratory variables was used to select a 1: 1 matched cohort. Results. Statins were prescribed for 37.8% of incident PD patients. Cumulative survival probabilities for statin user versus non-user were 87 versus 80% and 76 versus 69% at 3 and 5 years, respectively (P = 0.01). Statin prescription was associated with a 41% lower adjusted hazard ratio (HR) of death in the unmatched cohort [95% confidence interval (CI) = 0.42-0.82; P = 0.002]. The protective effect of statins was also observed in a subgroup analysis of patients with diabetic ESRD (HR = 0.53, 95% CI = 0.36-0.80; P = 0.002). After PS matching, the use of statins was also associated with improved survival (HR = 0.55, 95% CI = 0.38-0.79; P = 0.001) in incident PD patients. Conclusions. The use of statins was associated with a reduced risk of all-cause mortality. This association was independent of a history of cardiovascular disease or total cholesterol level. Future randomized clinical trials are warranted to confirm the beneficial effect of statin on PD patients.
URI
http://hdl.handle.net/YU.REPOSITORY/24148http://dx.doi.org/10.1093/ndt/gfr229
ISSN
0931-0509
Appears in Collections:
의과대학 > 내과학교실 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE